World Law Group’s Cannabis Group consists of member firm lawyers with expertise in the legal issues relevant to industry participants. Our expertise includes much more than compliance-related activities (licensing, product specific taxes, regulatory compliance, etc.). For example, our expertise is critical when advising clients about the issues most relevant to the industry, such as banking, protection of IP, cross-border investments, specialized financing issues, particularized tax rules and the unique challenges in the M&A market. These issues are often complicated by differences between local and federal laws, their overlap with international treaties, and differences in cultural and political acceptance for the industry’s products. The group’s goal is to be able to tap each other’s local knowledge to provide relevant and seamless client advice, especially in cross-border investments (including research arrangements), financing and import/export challenges, in this fast-growing market.
For more information, contact this group's leaders or Hanna Shea, WLG’s Manager, Communication & Network Development.
The year 2018 witnessed ongoing volatility in global markets, fueled by geopolitical uncertainty, rising trade tensions and slowing world economies.
Alabama has taken a significant step toward legalizing medical marijuana. Last week, the Alabama Senate passed a bill by a 17-6 vote that would create a process for prescribing medical marijuana to patients with certain enumerated conditions.
In a significant departure from past practice, Health Canada will now require prospective applicants for cannabis cultivation, processing or medical sales licences to have fully built regulatory-compliant facilities before it will review and process their licence applications.